Member Info for Maddog8

The market will be looking for solid sustainable earnings followed by using the profits wisely by smart acquisitions that grow the business organically in other areas than covid19.
Covid will be around for a while but at some point covid will be conquered in some way or another, by then Novacyt will be a broad brush diagnostics company with fingers in many pies.
As for share price, could shoot up several pounds from where we are, just need to evaluate all the deals that are inbound over next few weeks, still so much to come.

I had the same e-mail 1/2 hour ago, I hope this would suggest that the 25% is in the bag and all Mandy as to do now is approve every bodies registration for tomorrow’s session!!
Another late session ??

I’ve tried a couple of times to access, just get message saying “Your registration has not been approved yet”.
Guess we’ll have to wait until last minute!!

Kareem, I believe you can just take off / cancel your sell limit at any point in time. So for example if you had set your sell limit at £17 to be triggered say for next 60 days, and saw the share price at £15 and thought I’ll have some of that. You’d just remove £17 sell limit and execute trade as normal at £15.

Give your proxy vote to the chairman and he’ll decide what’s in the best interests for the company and shareholders.

Always nice to see Novacyt press release seen in the Daily Mail this evening.
May bring along some new PIs!!
Doesn’t tell us anything we don’t already know but will be seen by many readers.

https://mol.im/a/8744761

As Howard Wilkinson used to say “Brasso in fisto, brasso intacto”.
Keep them golden tickets under wraps for now until the games plays out a little more.

Chrisar, agree on this, £100m will be the minimum of what’s been forward sold now on the books. I’m sure it wouldn’t include government tenders wins/ contract extension etc. GM wouldn’t want to promise the market and not deliver etc.
A simple run rate of June sales revenue + H1 revenue would get revenue to c£200m gross margin with EBIT being c£130m for 2020.
Then you’ve got any French orders / contracts and the Winterplex product etc.

Yes, it baffles me as well. Must be a good reason why it’s been held back all these months. Hopefully get some answers at the AGM end of the month and then see how the dots have been joined up. Plenty to go with this yet over the next few months.

Full year earnings for 2020 expected to exceed 100 million euro would give a P/E ratio of approx 3 based on current share price.
Still very low.

Bluelight, I don’t know the rules around tenders/contracts but maybe they’ve just significantly extended and enhanced the contract already in place. Does this then warrant a RNS?
I’m just as frustrated as many on this board.

To make sure all the stock cupboards are full on tests!!! lol

I thought it was established a few weeks ago that the 200k euros was the total fees for the buy back programme not buying the shares.
The total shares that could be bought back was 10%, if my memory is correct, up to 12 euros per share, however, if the share price is only 4 euros they’ll buy back at the market value at that time.
Might be wrong, happy to be corrected.